Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 4
1947 3
1948 4
1949 3
1950 5
1951 6
1952 3
1953 4
1954 1
1955 2
1956 7
1957 5
1958 7
1959 11
1960 4
1961 5
1962 6
1963 8
1964 15
1965 12
1966 12
1967 7
1968 10
1969 13
1970 16
1971 21
1972 15
1973 28
1974 27
1975 22
1976 29
1977 13
1978 26
1979 26
1980 13
1981 23
1982 17
1983 27
1984 29
1985 44
1986 39
1987 52
1988 50
1989 57
1990 55
1991 54
1992 79
1993 76
1994 78
1995 108
1996 105
1997 129
1998 140
1999 121
2000 127
2001 126
2002 119
2003 150
2004 187
2005 212
2006 209
2007 253
2008 252
2009 268
2010 284
2011 317
2012 380
2013 382
2014 418
2015 462
2016 428
2017 499
2018 486
2019 547
2020 647
2021 747
2022 766
2023 505

Text availability

Article attribute

Article type

Publication date

Search Results

9,411 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Chang MY, Kim SJ, Pineles SL. Chang MY, et al. Ophthalmology. 2023 Aug;130(8):e30. doi: 10.1016/j.ophtha.2023.04.002. Epub 2023 May 2. Ophthalmology. 2023. PMID: 37140506 No abstract available.
Potential Therapeutic Strategies for Skeletal Muscle Atrophy.
Huang L, Li M, Deng C, Qiu J, Wang K, Chang M, Zhou S, Gu Y, Shen Y, Wang W, Huang Z, Sun H. Huang L, et al. Among authors: chang m. Antioxidants (Basel). 2022 Dec 26;12(1):44. doi: 10.3390/antiox12010044. Antioxidants (Basel). 2022. PMID: 36670909 Free PMC article. Review.
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance.
Hagenbeek TJ, Zbieg JR, Hafner M, Mroue R, Lacap JA, Sodir NM, Noland CL, Afghani S, Kishore A, Bhat KP, Yao X, Schmidt S, Clausen S, Steffek M, Lee W, Beroza P, Martin S, Lin E, Fong R, Di Lello P, Kubala MH, Yang MN, Lau JT, Chan E, Arrazate A, An L, Levy E, Lorenzo MN, Lee HJ, Pham TH, Modrusan Z, Zang R, Chen YC, Kabza M, Ahmed M, Li J, Chang MT, Maddalo D, Evangelista M, Ye X, Crawford JJ, Dey A. Hagenbeek TJ, et al. Among authors: chang mt. Nat Cancer. 2023 Jun;4(6):812-828. doi: 10.1038/s43018-023-00577-0. Epub 2023 Jun 5. Nat Cancer. 2023. PMID: 37277530 Free PMC article.
mTORC1 links pathology in experimental models of Still's disease and macrophage activation syndrome.
Huang Z, You X, Chen L, Du Y, Brodeur K, Jee H, Wang Q, Linder G, Darbousset R, Cunin P, Chang MH, Wactor A, Wauford BM, Todd MJC, Wei K, Li Y, Levescot A, Iwakura Y, Pascual V, Baldwin NE, Quartier P, Li T, Gianatasio MT, Hasserjian RP, Henderson LA, Sykes DB, Mellins ED, Canna SW, Charles JF, Nigrovic PA, Lee PY. Huang Z, et al. Among authors: chang mh. Nat Commun. 2022 Nov 28;13(1):6915. doi: 10.1038/s41467-022-34480-6. Nat Commun. 2022. PMID: 36443301 Free PMC article.
9,411 results